Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs

• Egile Nagusiak: Alessia Greco (Egilea), Francesca Coperchini (Egilea), Laura Croce (Egilea), Flavia Magri (Egilea), Marsida Teliti (Egilea), Mario Rotondi (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2023-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Cancer represents the main cause of death worldwide. Thyroid cancer (TC) shows an overall good rate of survival, however there is a percentage of patients that do not respond or are refractory to common therapies. Thus new therapeutics strategies are required. In the past decade, drug repositioning...